NLM Logo

non-Hodgkin's lymphoma protocol 8503 MeSH Supplementary Concept Data 2024


MeSH Supplementary
non-Hodgkin's lymphoma protocol 8503
Unique ID
C078247
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C078247
Entry Term(s)
NHL protocol 8503
UKALLXD ALL protocol, Medical Research Council
UKCCSG NHL protocol 8503
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Asparaginase
Daunorubicin
Methotrexate
Prednisolone
Vincristine
Mercaptopurine
Trimethoprim, Sulfamethoxazole Drug Combination
Frequency
2
Note
United Kingdom Children's Cancer Study Group (UKCCSG) continuous, intensive leukemia type regimen consisting of the above compounds; includes cranial irradiation and continuing chemotherapy for 2 years
Source
Br J Haematol 1992 Oct;82(2):310-6
Date of Entry
1992/12/21
Revision Date
2004/12/29
non-Hodgkin's lymphoma protocol 8503 Preferred
page delivered in 0.004s